Poster Abstract Session:
232. Diagnostics: Resistance Testing
Saturday, October 6, 2018: 12:30 PM-1:45 PM
Room: S Poster Hall

Tracks: Pediatric ID, Epidemiology and Infection Control, Adult ID


Presentations:
Comparative Evaluation of Ceftaroline Susceptibility Methods in Clinical Isolates of Methicillin-Resistant Staphylococcus aureus (MRSA): Results from a Multicenter Study
Lina M Rivas, MSc.; Maria Spencer, MSc.; Cecilia Zumaran, TM.; Marusella Lam, TM.; Francisco Silva, MD.; Marcela Cifuentes, MD.; Pamela Rojas, MD.; Stephanie Braun, MD.; Francisca Valdivieso, MD.; Margareta Mühlhauser, MD.; Mónica Lafourcade, MD.; Luz Fuenzalida, MD.; Victoria Moreno, MD.; Lorena Porte, MD; Rafael Araos, MD, MMSc; Patricia Garcia, MD; Jose M Munita, MD
Comparison of Plazomicin MIC Test Strip and Broth Microdilution MIC Results for 125 Enterobacteriaceae
Laura Koeth, BS. (MT, ASCP); Jeanna Difranco-Fisher, AS; Alisa W. Serio, PhD
Posters
  • 2060_IDWPOSTER.pdf (181.5 kB)
  • Impact of a Penicillin-Binding Protein 2a Rapid Diagnostic Test on Patients Who Present with Staphylococcus aureus Orthopedic Hardware Infections
    Jillian Hayes, PharmD; Whitney Nesbitt, PharmD, BCPS; Patty Wright, MD, FIDSA; Matthew Greene, MD; George Nelson, MD
    Posters
  • Alere IDWeek Poster JEH.pdf (639.0 kB)
  • Evaluation of Susceptibility Testing Methods for Fosfomycin against Enterobacteriaceae and Pseudomonas aeruginosa
    Elsa Piedad De La Cadena, MSc; Maria Fernanda Mojica, PhD; Cristhian Hernandez, MSc; Adriana Correa, PhD; Christian Pallares, MD, MSc; Maria Virginia Villegas, MD, MSc, FIDSA
    Extracellular Release of β-lactamase is Responsible for the Cefazolin Inoculum Effect (CzIE) in Methicillin-Susceptible Staphylococcus aureus.
    Lina P Carvajal, BSc; Alec Santiago, MD; Aura Echeverri, MSc; Rafael Rios, MSc; Sandra Rincon, MSc; Diana Panesso, PhD; Lorena Diaz, PhD; William Miller, MD; Zhizheng Sun, PhD; Timothy Palzkill, PhD; Cesar Arias, MD, PhD, FIDSA; Jinnethe Reyes, PhD
    Whole Genome Sequencing for Antimicrobial Resistance Prediction in MRSA and VRE: A Real World Application
    Ahmed Babiker, MBBS; Mustapha M. Mustapha, MBBS, PhD; Yohei Doi, MD, PhD; Lee H. Harrison, MD
    Posters
  • MRSA.VRE. 09.24 poster 2.pdf (1.9 MB)
  • Accelerated detection of carbapenem resistance mechanisms in Enterobacteriaceae by MALDI-TOF mass spectrometry using the direct-on-target microdroplet growth assay (DOT-MGA)
    Carlos Correa-Martinez, MD; Evgeny A. Idelevich, MD; Katrin Sparbier, PhD; Markus Kostrzewa, PhD; Karsten Becker, Prof.
    Novel Methodology for Same-Day Antimicrobial Susceptibility Testing on VITEK®2 for Gram-Negative Rod Bacteremia
    Catherine Hogan, MD, MSc; Indre Budvytiene, MS, CLS; Nancy Watz, CLS; Niaz Banaei, MD
    Automation Process Improving Microbiological Laboratory Efficiency
    Jacob Nichols, MD; Alanna Emrick, MLS (ASCP); Carolyn Gonzalez-Ortiz, M (ASCP); Kristen Fuhrmann, Pharm.D.; Ying Tabak, PhD; Latha Vankeepuram, MS; Stephen Kurtz, MS; David Sellers, RN; Fatma Levent, MD
    Posters
  • ID Week2018 Final.pdf (463.9 kB)
  • Antibiotic Therapy Effects on Enterobacteriaceae Detection Directly from Blood: Pilot Study Implications for Future Clinical Trial Design
    Amy Irwin, DNP, MS, RN; Sara Giddins, BS, MT (ASCP); Irina Yushkevich, MS; Alexiss Jeffers, BA; Michelle Barron, MD; Nancy Madinger, MD; Martin Fuchs, MS; Sungho Kim, PhD; Steven Metzger, BA; Connie Price, MD
    Evaluation of BD Phoenix™ CPO Detect Assay for Detection of Carbapenemase Producing Organisms in Clinical Samples in Singapore
    Partha P. De, MBBS, FRCPath; Esme Ng, BSc; Tzer Pin, Raymond Lin, FRCPA, MBBS, FAMS; Tim Hart, MD-PhD
    Multicenter Evaluation of the Etest Versus Agar Dilution for Susceptibility Testing of Helicobacter pylori
    Salika M. Shakir, Ph.D., D(ABMM); Joshua Otiso, MPH, MLS (ASCP); George Keller, SM (ASCP); Hillary Van Heule, MT (ASCP); Peggy Kohner, MT(ASCP); Nicolynn Cole, MT(ASCP); Audrey N. Schuetz, MD; Sandra S. Richter, MD; Marc Roger Couturier, Ph.D., D(ABMM)
    Posters
  • ID week 2018 poster_SS-2.pdf (552.5 kB)
  • Positive Clinical Impact of MALDI-TOF for the Management of Inpatient Pneumonia Without Additional Antimicrobial Stewardship (AS) Support
    Ann Marie Porreca, PharmD, BCPS; Jason Gallagher, PharmD, FCCP, FIDSA, BCPS; Kaede Ota Sullivan, MD
    Performance and impact evaluation of direct rapid antibiotic susceptibility testing on antibiotic treatment accuracy in clinical setting
    Jeong-Han Kim, M.D.; Taek Soo Kim, M.D.; Sang Hoon Song, M.D., Ph.D.; Jungil Choi, Ph.D.; Sangkwon Han, Ph.D.; Dong Young Kim, Ph.D.; Sunghoon Kwon, Ph.D.; Chang Kyung Kang, MD; Kyoung-Ho Song, M.D., Ph.D.; Pyeong Gyun Choe, M.D.; Ji Hwan Bang, M.D.; Eu Suk Kim, M.D., Ph.D.; Sang Won Park, M.D., Ph.D.; Hong Bin Kim, M.D., Ph.D.; Nam Joong Kim, M.D., Ph.D.; Myoung-Don Oh, M.D., Ph.D.; Wan Beom Park, M.D., Ph.D
    The Hypothetical Impact of Accelerate Pheno on Time to Appropriate Therapy (TTAT) and Time to Optimal Therapy (TTOT) in an Institution with an Established Antimicrobial Stewardship Program & Rapid Genotypic Organism/Resistance Marker Identification.
    Christopher Cooper, MD; Oryan Henig, MD; Keith Kaye, MD, MPH; Noman Hussain, MD; Zara Hussain, MBBS; Kathryn Deeds, BS; Hossein Salimnia, Ph.D.; Paul Lephart, Ph.D.; Umar Hayat, MD; Jinit Patel, MD; Jason M. Pogue, PharmD, BCPS-AQ ID
    Expanded Antibiotic Menu Demonstration for Novel Rapid Phenotypic Antimicrobial Susceptibility Testing Platform
    Eric Stern, PhD; Aleksandar Vacic, PhD; Kelly Flentie, PhD; Benjamin Spears, PhD; Nathan Purmort, MSEE; Felicia Giok, MS; Kayla DaPonte, BS; Sarah Scott, BS; Derek Puff, PhD; Frederick Floyd Jr., BS; Zhi Zhang, MS; Patrick Reilly, High School; Jamie Liu, High School; Emma Viveiros, High School; Nicholas Phelan, High School; Cicely Krebill, High School; Alec Flyer, PhD; David Smalley, PhD; David C. Hooper, MD; Mary Jane Ferraro, PhD, FIDSA
    Posters
  • Poster for ID Week v3.pdf (1.1 MB)
  • CME Credits: Maximum of 0.00 hours of AMA PRA Category 1 Credit™


    Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 3rd with the exception of research findings presented at the IDWeek press conferences.